EWM
RVNC
Edge Wealth Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,175
| Closed | -$68K | – | 478 |
|
|
2021
Q4 | $68K | Hold |
4,175
| – | – | 0.01% | 156 |
|
|
2021
Q3 | $116K | Hold |
4,175
| – | – | 0.02% | 118 |
|
|
2021
Q2 | $124K | Hold |
4,175
| – | – | 0.03% | 120 |
|
|
2021
Q1 | $117K | Hold |
4,175
| – | – | 0.02% | 125 |
|
|
2020
Q4 | $120K | Hold |
4,175
| – | – | 0.03% | 112 |
|
|
2020
Q3 | $105K | Sell |
4,175
-575
| -12% | -$14.5K | 0.02% | 144 |
|
|
2020
Q2 | $116K | Hold |
4,750
| – | – | 0.02% | 183 |
|
|
2020
Q1 | $70K | Hold |
4,750
| – | – | 0.02% | 204 |
|
|
2019
Q4 | $77K | Buy |
4,750
+1,500
| +46% | +$24.3K | 0.02% | 222 |
|
|
2019
Q3 | $42K | Hold |
3,250
| – | – | 0.01% | 264 |
|
|
2019
Q2 | $42K | Hold |
3,250
| – | – | 0.01% | 274 |
|
|
2019
Q1 | $51K | Buy |
3,250
+2,750
| +550% | +$43.2K | 0.01% | 240 |
|
|
2018
Q4 | $10K | Hold |
500
| – | – | ﹤0.01% | 403 |
|
|
2018
Q3 | $12K | Hold |
500
| – | – | ﹤0.01% | 414 |
|
|
2018
Q2 | $14K | Hold |
500
| – | – | ﹤0.01% | 385 |
|
|
2018
Q1 | $15K | Buy |
+500
| New | +$15K | ﹤0.01% | 336 |
|